Inhibition of Dipeptidyl Peptidase (DPP)-IV and α‑Glucosidase Activities by Pepsin-Treated Whey Proteins
Inhibitors of the enzymes dipeptidyl peptidase (DPP)-IV and α-glucosidase are two classes of pharmacotherapeutic agents used for the treatment of type 2 diabetes. In the present study, whey protein isolate (WPI), α-lactalbumin, β-lactoglobulin, serum albumin, and lactoferrin hydrolysates obtained by...
Gespeichert in:
Veröffentlicht in: | Journal of agricultural and food chemistry 2013-08, Vol.61 (31), p.7500-7506 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 7506 |
---|---|
container_issue | 31 |
container_start_page | 7500 |
container_title | Journal of agricultural and food chemistry |
container_volume | 61 |
creator | Lacroix, Isabelle M. E Li-Chan, Eunice C. Y |
description | Inhibitors of the enzymes dipeptidyl peptidase (DPP)-IV and α-glucosidase are two classes of pharmacotherapeutic agents used for the treatment of type 2 diabetes. In the present study, whey protein isolate (WPI), α-lactalbumin, β-lactoglobulin, serum albumin, and lactoferrin hydrolysates obtained by peptic digestion were investigated for their potential to serve as natural sources of DPP-IV and α-glucosidase inhibitors. Although inhibition of DPP-IV activity was observed in all pepsin-treated whey proteins studied, the α-lactalbumin hydrolysate showed the greatest potency with an IC50 value of 0.036 mg/mL. Conversely, only WPI, β-lactoglobulin, and α-lactalbumin hydrolysates displayed some inhibitory activity against α-glucosidase. This study suggests that peptides generated from whey proteins may have dual beneficial effects on glycemia regulation and could be used as functional food ingredients for the management of type 2 diabetes. |
doi_str_mv | 10.1021/jf401000s |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1444391412</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1444391412</sourcerecordid><originalsourceid>FETCH-LOGICAL-a369t-87207597fc515a1df515b377a5b1a56f08829896b49970b72efc33d1859e25e03</originalsourceid><addsrcrecordid>eNpt0EFO3DAUBmCrKipT2gUXKNkgwSLte3YcO0sEhY6E1JEK7TJyHLt4yMSDnSDNrlfoUbgIh-AkNcwAm66e5ff5l_UTsovwGYHil7ktAAEgviET5BRyjijfkgmkZS55idvkfYzzJCQX8I5sUyaZKBifkOtpf-UaNzjfZ95mJ25ploNrV102ezqoaLKDk9nsMJ_-zFTfZvd3D3_-nnWj9nG9PdKDu00BJmbN6vFVdH1-EYwaTJv9ujLpLvjBuD5-IFtWddF83Mwdcnn69eL4W37-_Wx6fHSeK1ZWQy4FBcErYTVHrrC1aTRMCMUbVLy0ICWtZFU2RVUJaAQ1VjPWouSVodwA2yEH69xl8DejiUO9cFGbrlO98WOssSgKVmGBNNHDNdXBxxiMrZfBLVRY1Qj1Y7f1S7fJftrEjs3CtC_yucwE9jdARa06G1SvXXx1oqSlxDK5vbWzytfqd0jm8gcFLACQoSjFa5LSsZ77MfSpr_986R8cmpX1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1444391412</pqid></control><display><type>article</type><title>Inhibition of Dipeptidyl Peptidase (DPP)-IV and α‑Glucosidase Activities by Pepsin-Treated Whey Proteins</title><source>MEDLINE</source><source>ACS Publications</source><creator>Lacroix, Isabelle M. E ; Li-Chan, Eunice C. Y</creator><creatorcontrib>Lacroix, Isabelle M. E ; Li-Chan, Eunice C. Y</creatorcontrib><description>Inhibitors of the enzymes dipeptidyl peptidase (DPP)-IV and α-glucosidase are two classes of pharmacotherapeutic agents used for the treatment of type 2 diabetes. In the present study, whey protein isolate (WPI), α-lactalbumin, β-lactoglobulin, serum albumin, and lactoferrin hydrolysates obtained by peptic digestion were investigated for their potential to serve as natural sources of DPP-IV and α-glucosidase inhibitors. Although inhibition of DPP-IV activity was observed in all pepsin-treated whey proteins studied, the α-lactalbumin hydrolysate showed the greatest potency with an IC50 value of 0.036 mg/mL. Conversely, only WPI, β-lactoglobulin, and α-lactalbumin hydrolysates displayed some inhibitory activity against α-glucosidase. This study suggests that peptides generated from whey proteins may have dual beneficial effects on glycemia regulation and could be used as functional food ingredients for the management of type 2 diabetes.</description><identifier>ISSN: 0021-8561</identifier><identifier>EISSN: 1520-5118</identifier><identifier>DOI: 10.1021/jf401000s</identifier><identifier>PMID: 23837435</identifier><identifier>CODEN: JAFCAU</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>alpha-glucosidase ; alpha-Glucosidases - analysis ; Animals ; beta-lactoglobulin ; Biological and medical sciences ; blood glucose ; Diabetes Mellitus, Type 2 - enzymology ; digestion ; Dipeptidyl Peptidase 4 - analysis ; Dipeptidyl-Peptidase IV Inhibitors - chemistry ; Enzyme Inhibitors - chemistry ; Food industries ; functional foods ; Fundamental and applied biological sciences. Psychology ; Glycoside Hydrolase Inhibitors ; Humans ; hydrolysates ; Hydrolysis ; ingredients ; inhibitory concentration 50 ; lactalbumin ; Milk and cheese industries. Ice creams ; Milk Proteins - chemistry ; noninsulin-dependent diabetes mellitus ; Pepsin A - chemistry ; peptides ; Peptides - chemistry ; Protein Hydrolysates - chemistry ; Rats ; serum albumin ; whey ; whey protein isolate ; Whey Proteins</subject><ispartof>Journal of agricultural and food chemistry, 2013-08, Vol.61 (31), p.7500-7506</ispartof><rights>Copyright © 2013 American Chemical Society</rights><rights>2014 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a369t-87207597fc515a1df515b377a5b1a56f08829896b49970b72efc33d1859e25e03</citedby><cites>FETCH-LOGICAL-a369t-87207597fc515a1df515b377a5b1a56f08829896b49970b72efc33d1859e25e03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jf401000s$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jf401000s$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>315,781,785,2766,27081,27929,27930,56743,56793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27626816$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23837435$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lacroix, Isabelle M. E</creatorcontrib><creatorcontrib>Li-Chan, Eunice C. Y</creatorcontrib><title>Inhibition of Dipeptidyl Peptidase (DPP)-IV and α‑Glucosidase Activities by Pepsin-Treated Whey Proteins</title><title>Journal of agricultural and food chemistry</title><addtitle>J. Agric. Food Chem</addtitle><description>Inhibitors of the enzymes dipeptidyl peptidase (DPP)-IV and α-glucosidase are two classes of pharmacotherapeutic agents used for the treatment of type 2 diabetes. In the present study, whey protein isolate (WPI), α-lactalbumin, β-lactoglobulin, serum albumin, and lactoferrin hydrolysates obtained by peptic digestion were investigated for their potential to serve as natural sources of DPP-IV and α-glucosidase inhibitors. Although inhibition of DPP-IV activity was observed in all pepsin-treated whey proteins studied, the α-lactalbumin hydrolysate showed the greatest potency with an IC50 value of 0.036 mg/mL. Conversely, only WPI, β-lactoglobulin, and α-lactalbumin hydrolysates displayed some inhibitory activity against α-glucosidase. This study suggests that peptides generated from whey proteins may have dual beneficial effects on glycemia regulation and could be used as functional food ingredients for the management of type 2 diabetes.</description><subject>alpha-glucosidase</subject><subject>alpha-Glucosidases - analysis</subject><subject>Animals</subject><subject>beta-lactoglobulin</subject><subject>Biological and medical sciences</subject><subject>blood glucose</subject><subject>Diabetes Mellitus, Type 2 - enzymology</subject><subject>digestion</subject><subject>Dipeptidyl Peptidase 4 - analysis</subject><subject>Dipeptidyl-Peptidase IV Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Food industries</subject><subject>functional foods</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Glycoside Hydrolase Inhibitors</subject><subject>Humans</subject><subject>hydrolysates</subject><subject>Hydrolysis</subject><subject>ingredients</subject><subject>inhibitory concentration 50</subject><subject>lactalbumin</subject><subject>Milk and cheese industries. Ice creams</subject><subject>Milk Proteins - chemistry</subject><subject>noninsulin-dependent diabetes mellitus</subject><subject>Pepsin A - chemistry</subject><subject>peptides</subject><subject>Peptides - chemistry</subject><subject>Protein Hydrolysates - chemistry</subject><subject>Rats</subject><subject>serum albumin</subject><subject>whey</subject><subject>whey protein isolate</subject><subject>Whey Proteins</subject><issn>0021-8561</issn><issn>1520-5118</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0EFO3DAUBmCrKipT2gUXKNkgwSLte3YcO0sEhY6E1JEK7TJyHLt4yMSDnSDNrlfoUbgIh-AkNcwAm66e5ff5l_UTsovwGYHil7ktAAEgviET5BRyjijfkgmkZS55idvkfYzzJCQX8I5sUyaZKBifkOtpf-UaNzjfZ95mJ25ploNrV102ezqoaLKDk9nsMJ_-zFTfZvd3D3_-nnWj9nG9PdKDu00BJmbN6vFVdH1-EYwaTJv9ujLpLvjBuD5-IFtWddF83Mwdcnn69eL4W37-_Wx6fHSeK1ZWQy4FBcErYTVHrrC1aTRMCMUbVLy0ICWtZFU2RVUJaAQ1VjPWouSVodwA2yEH69xl8DejiUO9cFGbrlO98WOssSgKVmGBNNHDNdXBxxiMrZfBLVRY1Qj1Y7f1S7fJftrEjs3CtC_yucwE9jdARa06G1SvXXx1oqSlxDK5vbWzytfqd0jm8gcFLACQoSjFa5LSsZ77MfSpr_986R8cmpX1</recordid><startdate>20130807</startdate><enddate>20130807</enddate><creator>Lacroix, Isabelle M. E</creator><creator>Li-Chan, Eunice C. Y</creator><general>American Chemical Society</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130807</creationdate><title>Inhibition of Dipeptidyl Peptidase (DPP)-IV and α‑Glucosidase Activities by Pepsin-Treated Whey Proteins</title><author>Lacroix, Isabelle M. E ; Li-Chan, Eunice C. Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a369t-87207597fc515a1df515b377a5b1a56f08829896b49970b72efc33d1859e25e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>alpha-glucosidase</topic><topic>alpha-Glucosidases - analysis</topic><topic>Animals</topic><topic>beta-lactoglobulin</topic><topic>Biological and medical sciences</topic><topic>blood glucose</topic><topic>Diabetes Mellitus, Type 2 - enzymology</topic><topic>digestion</topic><topic>Dipeptidyl Peptidase 4 - analysis</topic><topic>Dipeptidyl-Peptidase IV Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Food industries</topic><topic>functional foods</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Glycoside Hydrolase Inhibitors</topic><topic>Humans</topic><topic>hydrolysates</topic><topic>Hydrolysis</topic><topic>ingredients</topic><topic>inhibitory concentration 50</topic><topic>lactalbumin</topic><topic>Milk and cheese industries. Ice creams</topic><topic>Milk Proteins - chemistry</topic><topic>noninsulin-dependent diabetes mellitus</topic><topic>Pepsin A - chemistry</topic><topic>peptides</topic><topic>Peptides - chemistry</topic><topic>Protein Hydrolysates - chemistry</topic><topic>Rats</topic><topic>serum albumin</topic><topic>whey</topic><topic>whey protein isolate</topic><topic>Whey Proteins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lacroix, Isabelle M. E</creatorcontrib><creatorcontrib>Li-Chan, Eunice C. Y</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of agricultural and food chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lacroix, Isabelle M. E</au><au>Li-Chan, Eunice C. Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of Dipeptidyl Peptidase (DPP)-IV and α‑Glucosidase Activities by Pepsin-Treated Whey Proteins</atitle><jtitle>Journal of agricultural and food chemistry</jtitle><addtitle>J. Agric. Food Chem</addtitle><date>2013-08-07</date><risdate>2013</risdate><volume>61</volume><issue>31</issue><spage>7500</spage><epage>7506</epage><pages>7500-7506</pages><issn>0021-8561</issn><eissn>1520-5118</eissn><coden>JAFCAU</coden><abstract>Inhibitors of the enzymes dipeptidyl peptidase (DPP)-IV and α-glucosidase are two classes of pharmacotherapeutic agents used for the treatment of type 2 diabetes. In the present study, whey protein isolate (WPI), α-lactalbumin, β-lactoglobulin, serum albumin, and lactoferrin hydrolysates obtained by peptic digestion were investigated for their potential to serve as natural sources of DPP-IV and α-glucosidase inhibitors. Although inhibition of DPP-IV activity was observed in all pepsin-treated whey proteins studied, the α-lactalbumin hydrolysate showed the greatest potency with an IC50 value of 0.036 mg/mL. Conversely, only WPI, β-lactoglobulin, and α-lactalbumin hydrolysates displayed some inhibitory activity against α-glucosidase. This study suggests that peptides generated from whey proteins may have dual beneficial effects on glycemia regulation and could be used as functional food ingredients for the management of type 2 diabetes.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>23837435</pmid><doi>10.1021/jf401000s</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-8561 |
ispartof | Journal of agricultural and food chemistry, 2013-08, Vol.61 (31), p.7500-7506 |
issn | 0021-8561 1520-5118 |
language | eng |
recordid | cdi_proquest_miscellaneous_1444391412 |
source | MEDLINE; ACS Publications |
subjects | alpha-glucosidase alpha-Glucosidases - analysis Animals beta-lactoglobulin Biological and medical sciences blood glucose Diabetes Mellitus, Type 2 - enzymology digestion Dipeptidyl Peptidase 4 - analysis Dipeptidyl-Peptidase IV Inhibitors - chemistry Enzyme Inhibitors - chemistry Food industries functional foods Fundamental and applied biological sciences. Psychology Glycoside Hydrolase Inhibitors Humans hydrolysates Hydrolysis ingredients inhibitory concentration 50 lactalbumin Milk and cheese industries. Ice creams Milk Proteins - chemistry noninsulin-dependent diabetes mellitus Pepsin A - chemistry peptides Peptides - chemistry Protein Hydrolysates - chemistry Rats serum albumin whey whey protein isolate Whey Proteins |
title | Inhibition of Dipeptidyl Peptidase (DPP)-IV and α‑Glucosidase Activities by Pepsin-Treated Whey Proteins |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T07%3A27%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20Dipeptidyl%20Peptidase%20(DPP)-IV%20and%20%CE%B1%E2%80%91Glucosidase%20Activities%20by%20Pepsin-Treated%20Whey%20Proteins&rft.jtitle=Journal%20of%20agricultural%20and%20food%20chemistry&rft.au=Lacroix,%20Isabelle%20M.%20E&rft.date=2013-08-07&rft.volume=61&rft.issue=31&rft.spage=7500&rft.epage=7506&rft.pages=7500-7506&rft.issn=0021-8561&rft.eissn=1520-5118&rft.coden=JAFCAU&rft_id=info:doi/10.1021/jf401000s&rft_dat=%3Cproquest_cross%3E1444391412%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1444391412&rft_id=info:pmid/23837435&rfr_iscdi=true |